QuantRx Biomedical Corporation (OTC Bulletin Board: QTXB) has entered an agreement for the acquisition of NuRx Pharmaceuticals, Inc. (OTC.BB: NUXP). The transaction is structured to be a tax-free, all stock acquisition resulting in a combined company with no debt and a simplified ownership and capital structure.
Top Best Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign up for our Free Stock Newsletter.
From the acquisition, QuantRx's boosted competitive and financial position should help it to accelerate its efforts to take advantage of opportunities in the Point of Care diagnostic products market.
QuantRx Biomedical Corporation (OTCBB: QTXB) is focused on the development and commercialization of innovative products for advanced diagnosis of serious disease and health conditions.
Sign up for Top Best Penny Stocks' free newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.
Follow us on Twitter: http://www.Twitter.com/topbestps
About Us
Top Best Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer.
